Correction: Role of novel histone modifications in cancer

PDF  |  How to cite

Oncotarget. 2018; 9:19460-19460. https://doi.org/10.18632/oncotarget.25152

Metrics: PDF 2908 views  |   ?  

Muthu K. Shanmugam1, Frank Arfuso2, Surendar Arumugam10, Arunachalam Chinnathambi3, Jinsong Bian1, Sudha Warrier4, Ling Zhi Wang1,5, Alan Prem Kumar1,5,6,7,8, Kwang Seok Ahn9, Gautam Sethi1 and Manikandan Lakshmanan10,11

1Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
2Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia
3Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia
4Division of Cancer Stem Cells and Cardiovascular Regeneration, School of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India
5Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
6Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia
7National University Cancer Institute, National University Health System, Singapore, Singapore
8Department of Biological Sciences, University of North Texas, Denton, Texas, USA
9College of Korean Medicine, Kyung Hee University, Dongdaemun-gu, Seoul, Korea
10Institute of Molecular and Cell Biology, A*STAR, Biopolis Drive, Proteos, Singapore, Singapore
11Department of Pathology, National University Hospital Singapore, Singapore, Singapore

Published: April 10, 2018

This article has been corrected: The correct author name is given below:

Jinsong Bian

Original article: Oncotarget. 2018; 9:11414-11426. DOI: https://doi.org/10.18632/oncotarget.23356.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25152